Asperuloside ameliorates dopaminergic neuron injury in Parkinson’s disease by reprogramming microglial glucose metabolism in part through the AMPK pathway to induce M2 polarization
Experimental Brain Research · 2027-12 · 245 (1)
DOI: 10.1007/s00221-026-07431-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Brain Research, online erschienen am 19.11.2026. Verfasst von Xiang Sun und 5 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sun, X., Zhang, X., Zhao, Y., Zheng, W., Li, R., & Zhao, J. (2027). Asperuloside ameliorates dopaminergic neuron injury in Parkinson’s disease by reprogramming microglial glucose metabolism in part through the AMPK pathway to induce M2 polarization. Experimental Brain Research, 245(1). https://doi.org/10.1007/s00221-026-07431-6
Vancouver
Sun X, Zhang X, Zhao Y, Zheng W, Li R, Zhao J. Asperuloside ameliorates dopaminergic neuron injury in Parkinson’s disease by reprogramming microglial glucose metabolism in part through the AMPK pathway to induce M2 polarization. Experimental Brain Research. 2027;245(1). doi:10.1007/s00221-026-07431-6
BibTeX
@article{Sun2027,
author = {Sun, Xiang and Zhang, Xun and Zhao, Yawei and Zheng, Wei and Li, Ruijie and Zhao, Jieqiong},
title = {Asperuloside ameliorates dopaminergic neuron injury in Parkinson’s disease by reprogramming microglial glucose metabolism in part through the AMPK pathway to induce M2 polarization},
journal = {Experimental Brain Research},
year = {2027},
volume = {245},
number = {1},
doi = {10.1007/s00221-026-07431-6}
}
EUVIMED